PPIs
PPIs: weighing up the good and the bad
Proton pump inhibitors (PPIs) are the cornerstone of management for many gastrointestinal disorders. However, their increasingly widespread use is raising significant concerns, says Jala Moushi Proton pump inhibitors (PPIs) are …
Personalising OTC medicine options for adults with reflux
This 40-minute podcast will use a longitudinal case study to demonstrate how different adult reflux patients require different approaches to therapy at different stages of life, and how expert knowledge …
Watch: OTC management of gastro-oesophageal reflux symptoms
Dr Brett MacFarlane provides an overview of reflux symptoms and management, including optimal use of medicines Reflux symptoms are common in the community and pharmacists are often the first acute …
Over-the-counter (OTC) management of gastro-oesophageal reflux symptoms
Reflux symptoms are common in the community and pharmacists are often the first acute care practitioners sought by patients for advice and products for symptom relief. Pharmacists have an important …
Webinar: OTC management of gastro-oesophageal reflux symptoms
Join Dr Brett MacFarlane on this live webinar for an overview of reflux symptoms and management, including optimal use of medicines 23 May 2023 | 7-8.00PM AEST Reflux symptoms are …
Research Roundup
Debbie Rigby rounds up the latest in research news Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes In this population based …
Supporting the safe and effective use of proton pump inhibitors
Growing evidence suggests that long-term use of proton pump inhibitors (PPIs) may lead to serious adverse effects. By understanding the pharmacology of PPIs, their role in clinical practice and potential …
Simplifying gastro-oesophageal reflux disease management
This article discusses how the management of gastro-oesophageal reflux disease (GORD) can include over-the-counter (OTC) pharmacotherapies. It will review the available OTC treatment options for GORD, particularly the place of …
High-dose PPI changes ‘effective’: PBAC
Decrease in esomeprazole and increase in pantoprazole scripts likely due to restriction changes, says PBAC, though full picture obscured by lack of OTC and private data Restriction changes established in …
Research Roundup
Debbie Rigby rounds up the latest in research news Cardiopulmonary Consequences of Vaping in Adolescents This scientific statement for the American Heart Association details the harms associated with e-cigarettes, including …
High doses drop after moves to curb overprescribing
Patients have been shifting to lower dose PPIs following PBS listing changes, review reveals, but more investigation is needed The Drug Utilisation Sub-Committee (DUSC) of the PBAC has found positive …
Research Roundup
Debbie Rigby rounds up the latest in research news Medication-related hospital admissions in aged care residents In a retrospective analysis of DVA claims, nearly half of hospital admissions were preceded …